Antibody
Aβ 42, C-terminal
Quick Links
Clonality: monoclonal
Host: Mouse
Source: JRF/cAβ42/26
(Marc Mercken,
Johnson & Johnson Pharm. R&D,
Paper)
References:
Boland, 2010
Trinchese, 2008
Mi, 2007
Razmahel, 2002
Reactivity:
Reacts in: Human, Mouse
Immunogen/Epitope
immunogen = the carboxy terminal 10 residues of Ab1-42
Specificity
amyloid-beta 42, C-terminus
References
Paper Citations
- Boland B, Smith DA, Mooney D, Jung SS, Walsh DM, Platt FM. Macroautophagy is not directly involved in the metabolism of amyloid precursor protein. J Biol Chem. 2010 Nov 26;285(48):37415-26. PubMed.
- Trinchese F, Fa' M, Liu S, Zhang H, Hidalgo A, Schmidt SD, Yamaguchi H, Yoshii N, Mathews PM, Nixon RA, Arancio O. Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. J Clin Invest. 2008 Aug;118(8):2796-807. PubMed.
- Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, Sommer J, Schmidt SD, Nixon RA, Mathews PM, Levy E. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. Nat Genet. 2007 Dec;39(12):1440-2. PubMed.
- Rozmahel R, Mount HT, Chen F, Nguyen V, Huang J, Erdebil S, Liauw J, Yu G, Hasegawa H, Gu Y, Song YQ, Schmidt SD, Nixon RA, Mathews PM, Bergeron C, Fraser P, Westaway D, St George-Hyslop P. Alleles at the Nicastrin locus modify presenilin 1- deficiency phenotype. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14452-7. PubMed.
External Citations
Further Reading
News
- Link Between Synaptic Activity, Aβ Processing Revealed
- AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons
- Chicago: Dimebon Safe for 18 Months
- Paper Alert: Synaptic Activity Increases Aβ Release
- Sleep Deprivation Taxes Neurons, Racks Up Brain Aβ?
- Soluble Aβ—Bane or Boon? Real-time Data in Humans Yield New Insight
- Aβ and Mitochondria—When It Reigns, They Pore
- Trial Troika—Immunotherapy Interrupted, Lipitor Lags, Dimebon Delivers
- Washington: Alzhemed Non-story Yields Spotlight to Phase 2 Treatments
- Boston: Clinical Trial Results for Dimebon Unveiled
Comments / Questions
No Available Comments
Make a comment or submit a question
To make a comment you must login or register.